Constellation Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $124,847,000.
Profit Margin
| 2016 | 0 | -34.53M | |
|---|---|---|---|
| 2017 | 0 | -35.37M | |
| 2018 | 0 | -59.92M | |
| 2019 | 0 | -85.55M | |
| 2020 | 0 | -126.35M |
CNST Income Statement (2016 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 |
Operating exp. | |||||
Research and development | 95.50M | 66.45M | 48.76M | 32.61M | 27.88M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 124.84M | 86.05M | 61.24M | 39.08M | 33.65M |
Operating income | -124.84M | -86.05M | -61.24M | -39.08M | -33.65M |
Other income (expenses), net | -1.47M | 529K | 1.31M | 3.71M | -875K |
Income before tax | -126.31M | -85.52M | -59.92M | -35.37M | -34.53M |
Income tax expense | 39K | 24K | 1.54M | 4.61M | 470K |
Net income | -126.35M | -85.55M | -59.92M | -35.37M | -34.53M |
Earnings per share | |||||
Basic EPS | -4.49 | -3.04 | -5 | -3.03 | -0.72 |
Diluted EPS | -4.49 | -3.04 | -5 | -3.03 | -0.72 |
| Data source | Data source | Data source |